Thyroid Eye Disease Treatments Market by Drug, Route of Administration, Treatment, Diagnosis, Distribution - Global Forecast 2025-2030- Product Image

Sale

Thyroid Eye Disease Treatments Market by Drug, Route of Administration, Treatment, Diagnosis, Distribution - Global Forecast 2025-2030

Report
181 Pages
October 2024
Region: Global
360iResearch™
ID: 5012989

UP TO €692EUR$697USD£574GBP OFF until Dec 31^st 2024

The Thyroid Eye Disease Treatments Market grew from USD 298.07 million in 2023 to USD 326.24 million in 2024. It is expected to continue growing at a CAGR of 9.52%, reaching USD 563.40 million by 2030.

The market for thyroid eye disease (TED) treatments is defined by the increasing incidence of the condition, driven by factors such as rising autoimmune thyroid disorders and growing awareness. TED is characterized by an autoimmune response affecting the tissues around the eyes, requiring multidisciplinary approaches like medication, radiation therapy, and surgical interventions. The necessity for treatment arises from its potential to impair vision and quality of life, making timely intervention critical. The application of TED treatments is primarily in healthcare settings, including hospitals and specialty clinics, with end-use spanning from affected individuals and medical practitioners specializing in ophthalmology and endocrinology. The market is heavily influenced by growth factors like technological advancements in therapeutics, the advent of targeted biologics, and substantial backing from pharmaceutical companies in R&D initiatives.

Key opportunities in this space include expanding geographic reach to emerging markets and harnessing biotechnological advances to create more effective and less invasive treatment options. As regulatory agencies approve new therapies, such as teprotumumab, companies should consider the potential for these approvals to drive market growth. On the other hand, market growth is challenged by high treatment costs, limited availability of specialized care, and stringent government regulations that can slow down the approval process. Other obstacles include public awareness shortfalls and the stigmatization of thyroid-related ailments, which limit patient outreach.

Innovation is pivotal, with opportunities lying in personalized medicine and developing less intrusive surgical procedures or biologics that offer improved safety profiles. Advancements in genetic research also present novel avenues for understanding TED pathophysiology, leading to targeted therapies. The nature of the TED treatment market is dynamic, competitive, and shaped by continuous scientific advancements and evolving therapeutic approaches, urging stakeholders to maintain agility and keep abreast of emerging clinical data to optimize development strategies and market positioning.

Understanding Market Dynamics in the Thyroid Eye Disease Treatments Market

The Thyroid Eye Disease Treatments Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- High Prevalence of Autoimmune Diseases such as Grave’s Disease and Hashimoto's Thyroiditis
- Awareness Raising National Health Programs Coupled with Favorable Reimbursement Policies related to Thyroid Disease Treatment
- Increasing Iodine Disorder and Thyroid Tumors Screening
Market Restraints
- Limited Accessibility, Affordability, and Unmeasured Side Effects
Market Opportunities
- Improving Healthcare Infrastructure, Increasing Number of Ophthalmologists
- Growing Early Diagnosis Rate Coupled with Developing Novel Therapy for the Thyroid Eye
Market Challenges
- Limitation Associated with the Availability of any Definitive Thyroid Eye Treatment

Exploring Porter’s Five Forces for the Thyroid Eye Disease Treatments Market

Porter’s Five Forces framework further strengthens the insights of the Thyroid Eye Disease Treatments Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Thyroid Eye Disease Treatments Market

External macro-environmental factors deeply influence the performance of the Thyroid Eye Disease Treatments Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Thyroid Eye Disease Treatments Market

The Thyroid Eye Disease Treatments Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Thyroid Eye Disease Treatments Market

The Thyroid Eye Disease Treatments Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Thyroid Eye Disease Treatments Market

The Thyroid Eye Disease Treatments Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Thyroid Eye Disease Treatments Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories Inc., AbbVie, Inc., Akron Inc., AMRI Global, Bausch & Lomb Incorporated, Bayer AG, Eyevance Pharmaceuticals LLC, F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, GlaxoSmithKline PLC, Horizon Therapeutics PLC, Immunovant, Inc., Kala Pharmaceuticals, Inc., Mabxience Research Sl, Merck KGaA, Pfizer Inc., RLC Labs, Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Viatris.

Market Segmentation & Coverage

This research report categorizes the Thyroid Eye Disease Treatments Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug
- Corticosteroid
- Monoclonal Antibody
- Vitamin
Route of Administration
- Oral
- Topical
Treatment
- Medication
- Radioactive Iodine Therapy
- Surgery
Diagnosis
- Blood Test
- Imaging Test
- Orbital Ultrasound
- Physical Exam
- Radioactive Iodine Uptake Test
Distribution
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High Prevalence of Autoimmune Diseases such as Grave’s Disease and Hashimoto's Thyroiditis
5.1.1.2. Awareness Raising National Health Programs Coupled with Favorable Reimbursement Policies related to Thyroid Disease Treatment
5.1.1.3. Increasing Iodine Disorder and Thyroid Tumors Screening
5.1.2. Restraints
5.1.2.1. Limited Accessibility, Affordability, and Unmeasured Side Effects
5.1.3. Opportunities
5.1.3.1. Improving Healthcare Infrastructure, Increasing Number of Ophthalmologists
5.1.3.2. Growing Early Diagnosis Rate Coupled with Developing Novel Therapy for the Thyroid Eye
5.1.4. Challenges
5.1.4.1. Limitation Associated with the Availability of any Definitive Thyroid Eye Treatment
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Thyroid Eye Disease Treatments Market, by Drug

6.1. Introduction
6.2. Corticosteroid
6.3. Monoclonal Antibody
6.4. Vitamin

7. Thyroid Eye Disease Treatments Market, by Route of Administration

7.1. Introduction
7.2. Oral
7.3. Topical

8. Thyroid Eye Disease Treatments Market, by Treatment

8.1. Introduction
8.2. Medication
8.3. Radioactive Iodine Therapy
8.4. Surgery

9. Thyroid Eye Disease Treatments Market, by Diagnosis

9.1. Introduction
9.2. Blood Test
9.3. Imaging Test
9.4. Orbital Ultrasound
9.5. Physical Exam
9.6. Radioactive Iodine Uptake Test

10. Thyroid Eye Disease Treatments Market, by Distribution

10.1. Introduction
10.2. Hospital Pharmacy
10.3. Online Pharmacy
10.4. Retail Pharmacy

11. Americas Thyroid Eye Disease Treatments Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Thyroid Eye Disease Treatments Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Thyroid Eye Disease Treatments Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
14.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. THYROID EYE DISEASE TREATMENTS MARKET RESEARCH PROCESS
FIGURE 2. THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2030 (%)
FIGURE 15. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 19. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 25. THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. THYROID EYE DISEASE TREATMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. THYROID EYE DISEASE TREATMENTS MARKET DYNAMICS
TABLE 7. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY CORTICOSTEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY VITAMIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY BLOOD TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY IMAGING TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ORBITAL ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY PHYSICAL EXAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RADIOACTIVE IODINE UPTAKE TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 44. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 45. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 46. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 48. CANADA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 49. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 50. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 53. MEXICO THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 71. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 72. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 73. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 75. CHINA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 76. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 77. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 80. INDIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 86. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 87. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 90. JAPAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 116. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 117. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 118. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 120. THAILAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 132. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 133. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 135. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 136. DENMARK THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 137. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 138. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 139. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 140. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 141. EGYPT THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 142. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 143. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 145. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 146. FINLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 147. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 148. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 151. FRANCE THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 152. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 153. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 154. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 156. GERMANY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 162. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 163. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 164. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 165. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 166. ITALY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 177. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 178. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 179. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 180. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 181. NORWAY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 182. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 183. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 186. POLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 187. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 188. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 191. QATAR THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 207. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 208. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 209. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 210. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 211. SPAIN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 223. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 225. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 226. TURKEY THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DRUG, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DIAGNOSIS, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM THYROID EYE DISEASE TREATMENTS MARKET SIZE, BY DISTRIBUTION, 2018-2030 (USD MILLION)
TABLE 237. THYROID EYE DISEASE TREATMENTS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 238. THYROID EYE DISEASE TREATMENTS MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Thyroid Eye Disease Treatments Market, which are profiled in this report, include:

Abbott Laboratories Inc.
AbbVie, Inc.
Akron Inc.
AMRI Global
Bausch & Lomb Incorporated
Bayer AG
Eyevance Pharmaceuticals LLC
F. Hoffmann-La Roche AG
Fujifilm Holdings Corporation
GlaxoSmithKline PLC
Horizon Therapeutics PLC
Immunovant, Inc.
Kala Pharmaceuticals, Inc.
Mabxience Research Sl
Merck KGaA
Pfizer Inc.
RLC Labs
Sanofi S.A.
Teva Pharmaceutical Industries Ltd.
Viatris

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	181
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 326.24 Million
Forecasted Market Value ( USD ) by 2030	$ 563.4 Million
Compound Annual Growth Rate	9.5%
Regions Covered	Global
No. of Companies Mentioned	20

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3518EUR$3,545USD£2,919GBP €3909EUR$3,939USD£3,243GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6224EUR$6,272USD£5,164GBP €6915EUR$6,969USD£5,738GBP

Understanding Market Dynamics in the Thyroid Eye Disease Treatments Market

Exploring Porter’s Five Forces for the Thyroid Eye Disease Treatments Market

Applying PESTLE Analysis to the Thyroid Eye Disease Treatments Market

Analyzing Market Share in the Thyroid Eye Disease Treatments Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Thyroid Eye Disease Treatments Market

Strategic Recommendations for Success in the Thyroid Eye Disease Treatments Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Graves Ophthalmopathy - Pipeline Insight, 2024

Thyroid Eye Disease (TED) - Market Insight, Epidemiology and Market Forecast - 2034

Thyroid Eye Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Graves Disease Market by Diagnosis, Treatment, Route of Administration, Distribution Channel, End User - Global Forecast 2025-2030

Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030

About the Thyroid Eye Disease Treatment Market